Back
Salesforce Vs. The Chemours Industry Stock Comparison
Sell
50
CRM
Salesforce
Last Price:
276.71
Seasonality Move:
7.26%
Buy
65
CC
The Chemours
Last Price:
28.90
Seasonality Move:
3.31%
Sell
50
Salesforce (CRM)
is a Sell
Is Salesforce a Buy, Sell or Hold?
- The current Salesforce [CRM] share price is $275.17. The Score for CRM is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- CRM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
65
The Chemours (CC)
is a Buy
Is The Chemours a Buy, Sell or Hold?
- The current The Chemours [CC] share price is $28.43. The Score for CC is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
- CC is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CRM Stock Price Chart
What is Salesforce's stock price today?
-
The Salesforce share price today is $275.17
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRM is experiencing buying pressure, which is a positive indicator for future bullish movement.
CC Stock Price Chart
What is The Chemours's stock price today?
-
The The Chemours share price today is $28.43
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CC is experiencing buying pressure, which is a positive indicator for future bullish movement.
CRM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -4.55 | Sell |
| Relative Strength Index (14 RSI): | 42.8 | Sell |
| Chaikin Money Flow: | 4269033 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (269.01 - 291.65) | Sell |
| Bollinger Bands (100): | (268.47 - 300.71) | Sell |
CC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.16 | Buy |
| Relative Strength Index (14 RSI): | 58.53 | Buy |
| Chaikin Money Flow: | 1086844 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (26.28 - 27.62) | Buy |
| Bollinger Bands (100): | (25.79 - 30.97) | Buy |
CRM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 273.8 | Buy |
| 20-day SMA: | 275.17 | Sell |
| 50-day SMA: | 292.35 | Sell |
| 200-day SMA: | 250.6 | Buy |
| 8-day EMA: | 275.41 | Sell |
| 20-day EMA: | 278.41 | Sell |
| 50-day EMA: | 283.89 | Sell |
| 200-day EMA: | 257.61 | Buy |
CC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 27.09 | Buy |
| 20-day SMA: | 26.83 | Buy |
| 50-day SMA: | 26.44 | Buy |
| 200-day SMA: | 28.96 | Sell |
| 8-day EMA: | 27.43 | Buy |
| 20-day EMA: | 27.13 | Buy |
| 50-day EMA: | 27.24 | Buy |
| 200-day EMA: | 28.74 | Sell |
Salesforce Earnings Growth & CRM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.34 per share, an increase next quarter of $0.19 per share, an increase this year of $3.27 per share, and an increase next year of $1.60 per share.
The Chemours Earnings Growth & CC Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.06 per share, an increase next quarter of $0.58 per share, a decrease this year of $0.98 per share, and an increase next year of $1.82 per share.
Salesforce Technical Analysis
| Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
The Chemours Technical Analysis
| Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||